Adjuvant Aromatase Inhibitor Therapy in Patients with Stage I Breast Cancer at a Regional Oncology Center in Israel: Implementation of a ‘Switching' Policy in Postmenopausal Patients after Initial Tamoxifen

David B. Geffen,Margarita Tokar,Sara Abu-Ghanem,R. Braunstein,Michael Koretz,N. Amir,Bertha Delgado,Neta Sion-Vardi,Samuel Ariad,Irena Lazarev

Adjuvant Aromatase Inhibitor Therapy in Patients with Stage I Breast Cancer at a Regional Oncology Center in Israel: Implementation of a ‘Switching' Policy in Postmenopausal Patients after Initial Tamoxifen

2013

David B. Geffen
Margarita Tokar
Sara Abu-Ghanem
R. Braunstein
Michael Koretz
N. Amir
Bertha Delgado
Neta Sion-Vardi
Samuel Ariad
Irena Lazarev

Objective: To analyze the implementation of a switching policy of adjuvant aromatase inhibitor (AI) therapy sequentially after tamoxifen in consecutively treated

Keywords:

Breast cancer
Stage I breast cancer
Adjuvant
Aromatase inhibitor
Tamoxifen
Medicine
Oncology
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations